OM-001

N/A

Report date: 2025/09/25 16:49:47

Base Information

Drug NameOM-001
Drug Alias Name3’sialyllactose3’SL3′-Monosialyllactose3′-O -Sialyllactose3′-Sialylactose +[16] 
ClassificationNatural product/Extract > Animal extractSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsAutism Spectrum DisorderDermatitis, AtopicArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntrinsic Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntrinsic Medicine Inc
Inactive CompaniesN/A
Active IndicationsAutism Spectrum DisorderDermatitis, AtopicArthritis, Rheumatoid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A